ArticleCancer research2016

Quantitative phosphotyrosine profiling of patient-derived xenografts identifies therapeutic targets in pediatric leukemia.

Sibasish Dolai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.